Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editor's Note: Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth.
Moreno-Smith M, Lu C, Shahzad MMK, Pena GNA, Allen JK, Stone RL, Mangala LS, Han HD, Kim HS, Farley D, Berestein GL, Cole SW, Lutgendorf SK, Sood AK. Moreno-Smith M, et al. Among authors: kim hs. Clin Cancer Res. 2021 Aug 1;27(15):4451. doi: 10.1158/1078-0432.CCR-21-2117. Clin Cancer Res. 2021. PMID: 34341056 No abstract available.
Dopamine blocks stress-mediated ovarian carcinoma growth.
Moreno-Smith M, Lu C, Shahzad MM, Pena GN, Allen JK, Stone RL, Mangala LS, Han HD, Kim HS, Farley D, Berestein GL, Cole SW, Lutgendorf SK, Sood AK. Moreno-Smith M, et al. Among authors: kim hs. Clin Cancer Res. 2011 Jun 1;17(11):3649-59. doi: 10.1158/1078-0432.CCR-10-2441. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531818 Free PMC article.
Editor's Note: Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles.
Han HD, Mangala LS, Lee JW, Shahzad MMK, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK. Han HD, et al. Among authors: kim hs. Clin Cancer Res. 2021 Aug 1;27(15):4453. doi: 10.1158/1078-0432.CCR-21-2119. Clin Cancer Res. 2021. PMID: 34341058 No abstract available.
Surgical stress promotes tumor growth in ovarian carcinoma.
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK. Lee JW, et al. Among authors: kim hs. Clin Cancer Res. 2009 Apr 15;15(8):2695-702. doi: 10.1158/1078-0432.CCR-08-2966. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351748 Free PMC article.
Functional roles of Src and Fgr in ovarian carcinoma.
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK. Kim HS, et al. Clin Cancer Res. 2011 Apr 1;17(7):1713-21. doi: 10.1158/1078-0432.CCR-10-2081. Epub 2011 Feb 7. Clin Cancer Res. 2011. PMID: 21300758 Free PMC article.
Editor's Note: Functional Roles of Src and Fgr in Ovarian Carcinoma.
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MMK, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK. Kim HS, et al. Clin Cancer Res. 2021 Aug 1;27(15):4452. doi: 10.1158/1078-0432.CCR-21-2118. Clin Cancer Res. 2021. PMID: 34341057 No abstract available.
Targeted gene silencing using RGD-labeled chitosan nanoparticles.
Han HD, Mangala LS, Lee JW, Shahzad MM, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK. Han HD, et al. Among authors: kim hs. Clin Cancer Res. 2010 Aug 1;16(15):3910-22. doi: 10.1158/1078-0432.CCR-10-0005. Epub 2010 Jun 10. Clin Cancer Res. 2010. PMID: 20538762 Free PMC article.
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.
Lee JW, Stone RL, Lee SJ, Nam EJ, Roh JW, Nick AM, Han HD, Shahzad MM, Kim HS, Mangala LS, Jennings NB, Mao S, Gooya J, Jackson D, Coleman RL, Sood AK. Lee JW, et al. Among authors: kim hs. Clin Cancer Res. 2010 May 1;16(9):2562-70. doi: 10.1158/1078-0432.CCR-10-0017. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388851 Free PMC article.
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.
Vivas-Mejia P, Benito JM, Fernandez A, Han HD, Mangala L, Rodriguez-Aguayo C, Chavez-Reyes A, Lin YG, Carey MS, Nick AM, Stone RL, Kim HS, Claret FX, Bornmann W, Hennessy BT, Sanguino A, Peng Z, Sood AK, Lopez-Berestein G. Vivas-Mejia P, et al. Among authors: kim hs. Clin Cancer Res. 2010 Jan 1;16(1):184-94. doi: 10.1158/1078-0432.CCR-09-1180. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028751 Free PMC article.
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.
Merritt WM, Danes CG, Shahzad MM, Lin YG, Kamat AA, Han LY, Spannuth WA, Nick AM, Mangala LS, Stone RL, Kim HS, Gershenson DM, Jaffe RB, Coleman RL, Chandra J, Sood AK. Merritt WM, et al. Among authors: kim hs. Cancer Biol Ther. 2009 Aug;8(16):1596-603. doi: 10.4161/cbt.8.16.9004. Epub 2009 Aug 13. Cancer Biol Ther. 2009. PMID: 19738426 Free PMC article.
15,684 results
You have reached the last available page of results. Please see the User Guide for more information.